Coronavirus disease 2019 (COVID-19) has been reported to cause cardiovascular
complications such as myocardial injury, thromboembolic events, arrhythmia, and heart …

Abstract Coronavirus Disease 2019 (COVID-19) is a rapidly progressing global pandemic
that may present with a variety of cardiac manifestations including, but not limited to …

(SARS)-Coronavirus (CoV)-2. The main clinical manifestation that leads to hospital
admission is the novel coronavirus pneumonia. The latter is characterized by partial filling of …

Abstract Purpose of Review The risk of cardiovascular complications due to SARS-CoV-2
are significantly increased within the first 6 months of the infection. Patients with COVID-19 …

Background A small minority of people with coronavirus disease 2019 (COVID‐19) develop
a severe illness, characterised by inflammation, microvascular damage and coagulopathy …

A highly pathogenic human coronavirus, severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), has been recently recognized in Wuhan, China, as the cause of the …

Objectives The clinical impact of SARS-CoV-2 has varied across countries with varying
cardiovascular manifestations. We review the cardiac presentations, in-hospital outcomes …

To date, 92,111,432 of coronavirus disease 2019 (COVID-19), cases were confirmed
worldwide and the number of asymptomatic patients remains largely unknown. There are …

The term Long COVID (or Post COVID) describes a condition characterized by persistence
of symptoms for at least 12 weeks after the onset of COVID-19. It may last several months but …

Pre‐existing cardiovascular disease (CVD) increases the morbidity and mortality of COVID‐
19 and is strongly associated with poor disease outcomes. However, SARS‐CoV‐2 infection …